Ethical clearance

Responsible Open Science involves adhering to the highest research ethics and integrity standards. The University of Antwerp deems it necessary for all researchers to always respect the fundamental ethical norms and values in their scientific research and knowledge creation to guarantee the highest quality of research. In this way, the university can present itself as a reliable and responsible knowledge actor and partner towards the government and society as a whole.  

As a researcher, you are responsible for critically asking yourself some questions concerning your research design. Will your research involve experiments on humans or animals? Will you conduct surveys or interviews with human participants? Do you use or develop technologies that might possibly be used for not only civilian but also military purposes (dual use) or can be misused for unethical purposes? Is there any chance your research activity or a partner involved might – directly or indirectly – violate human rights? If the answer to one or more of these questions is positive, you might have to apply for ethical clearance from one of the ethics committees at the University of Antwerp.  

Visit the Ethics Screening web pages to learn more about the ethics committees and contact the Ethics Team about specific issues.  

Note that in case of clinical trials or animal experiments, it is lawfully required to apply for ethical clearance.  

In case there’s a direct military application of your research or in case it could be abused for terroristic purposes, researchers have an obligation to report it to the proper internal contact point regarding dual-use items or potential misuse of their research. Visit the Ethics committee for Science and Technology webpages to learn about dual use and misuse of research and contact the dual use commission about specific issues.  

Privacy

Unlike other aspects of the research cycle, Open Science and privacy might be in tension. If you will be working with human participants it is important to take the necessary precautions to ensure their privacy. We advise you to make a Data Protection Impact Assessment (DPIA) at the start of your project on personal or sensitive data, (pseudo-)anonymization of your data, data security, etc. Consider whether and how you will obtain informed consent from the participants concerning data access, preservation, and sharing.

Visit the Privacy Office pages to learn more about privacy and principles of GDPR or contact the privacy commission with specific questions.

IP and valorisation

Ground-breaking research conducted at the University of Antwerp is creating an impact on society. The university’s role has broadened to that of a driving force in innovation. Some questions on intellectual property rights (IPR) might raise during a research project. ALLEA Statement is clear that there is no fundamental opposition between Open Science and the valorisation of research through the assertion of intellectual property rights. There is, however, a need to modernize patent law to better align it with the Open Science principles.

If you think your data potentially has commercial value, you should always try to obtain a clear overview of the various owners of the research data as early as possible (preferably before or at the start of the project) and, if necessary, conclude the necessary contracts. 

If you will be working in a collaboration with other research groups, institutes, or companies it is then important to make a third-party agreement, which limits the dissemination or exploitation of the data.

 For support, visit the Valorisation Office website and consult IOF or valosization managers and contact the legal department.

Nagoya Protocol

About

Every country has rights over the genetic resources within its borders (for example, animals and plants). The Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization is an international agreement that determines obligations regarding access and benefit sharing (ABS) of the Convention on Biological Diversity (CBD). Researchers of the University of Antwerp have a legal obligation to comply with the Nagoya Protocol.

Guiding principles of the Nagoya Protocol concerning equitable sharing and benefits complement the FAIR principles in particular and the Open Science principles in general, especially concerning transparency and accountability. Nevertheless, the implementation of the Nagoya Protocol still lacks sufficient information and training. That is why this section offers detailed information on the Nagoya Protocol implementation at UAntwerpen.

The Nagoya Protocol applies to:

  1. Genetic resources are accessed from a country that is a party to the Protocol and that enforces ABS legislation (accessed directly from the country of origin or via third parties).
  2. The utilization of genetic resources after 12 October 2014.

The Nagoya Protocol does not apply to:

  1. Human genetic resources.
  2. Genetic resources already covered by specialized international documents (for example, the International Treaty on Plant Genetic Resources for Food and Agriculture or the framework for pandemic preparedness of the World Health Organization)
  3. Genetic resources as traded commodities (for example, agricultural, fishery, or forestry products - whether for direct consumption or as ingredients in food and drink products).
  4. Genetic resources that were acquired before the Protocol came into effect.

Some of the specific cases in which researchers may come into contact with the Nagoya Protocol include:

  • Acquiring genetic material.
  • Granting access to genetic resources to researchers or units at the university or external organizations.
  • Performing fieldwork abroad.
  • Presenting materials from collections (laboratories, museums, libraries, botanical gardens, etc.).
  • Completing ethics checklists for research funding applications (for example, Horizon and FWO).
  • Commercializing or selling resources or products linked to genetic material.
  • Patenting important findings based on genetic materials.
  • Etc.

Researchers who are not sure whether their research falls under the Nagoya Protocol are required to use the Due Diligence Tool under the tab Procedure and Guidelines to determine their next steps.

Researchers who use genetic material are required to follow steps described under the tab Procedure and guidelines to ensure that genetic resources are accessed in accordance with applicable access and benefit sharing laws implemented by the provider country.

Procedures & Guidelines

Researchers who intend to acquire or utilize genetic resources (accessed directly from the country of origin or via third parties) must exercise due diligence. This means that they have to undertake a process to determine whether the accessed genetic resource meets legal requirements on ABS

Due Diligence tool

1. Determine whether the Nagoya Protocol applies to the genetic material  
      → Refer to the Due Diligence Tool (Pintra after login) which is a step-by-step checklist that helps you determine
           whether the Nagoya Protocol is applicable in your case.

2.  If you determine that your research does not fall within the scope of the
        Nagoya Protocol
→ follow the steps:

a.    Keep a “due diligence record” of the actions you used to determine the genetic resource was not within the scope of the Protocol.

b.    Check if there is national legislation that should be followed (unrelated to the Nagoya Protocol) as it is sometimes the case.   

Accessing material

1. If your research does fall within the scope of the Nagoya Protocol 
    → Follow the due diligence process described below and in the Nagoya communication manual (Pintra after login).​

a.     Identify information on the provider country

  •  Use the site of the Access and Benefit-Sharing Clearing House (ABSCH) to identify whether the provider country is a party to the Protocol and has established measures, and procedures regarding the genetic resource you intend to use.
  • Also, use the same site to identify the national contact points of the provider country.
  • If ABSCH does not provide any information on the regulations, but there are reasons to assume there is, indeed, a set of laws or regulations in place, you should make an effort to establish contact with the national contact point in the provider country.

b.     Perform due diligence steps

Make a reasonable effort to gain informed consent and agree on the terms and conditions of access. The due diligence steps vary depending on how the genetic resource is accessed:​

  • Indirect access (genetic resource accessed via a third party)
    • Identify which third party is your intermediary (registered collection, ex-situ facility).
    • Identify whether the third party has established PIC and MAT for the genetic resource you intend to use and obtain them (IRCC or equivalent also possible).
    • If no PIC and MAT, apply for new or modified PIC and MAT.
  • Direct access (genetic resource accessed directly from the country of origin)
    • Using ABSCH website, identify whether there are requirements to obtain PIC (prior informed consent) and MAT (mutually agreed terms - for genetic materials obtained from indigenous or local communities - negotiated by the legal department of the university). Some countries require both, some neither.
    • Identify if there is already an internationally recognized certificate of compliance (IRCC).
    • If you are not sure, contact the national contact point indicated on the ABSCH website.
    • Identify whether you need other permits (for example, export control).

c.      Keep records 

  • →Due diligence records (documentation and communication) must be stored for a minimum of 20 years after the end of utilization. The records can be requested by the Government.

Providing access

  1. Make sure that access to genetic resources is in accordance with requirements set out in PIC and MAT.
  2. Make sure that IRCC (or equivalent is associated with access to the genetic resource.
  3. Inform the new holder that the transferred information must be kept by the new holder and included in any subsequent transfers.
  4. Keep records of such sharing/access for 20 years. These records may be inspected by the Government.

For specific questions regarding the application of the Nagoya Protocol, contact the RDM-team

FAQS

  1. What are genetic resources?
    The genetic material of actual or potential value.
  2. What is genetic material?
    Any material of plant, animal, microbial or other origin containing functional units of heredity.
  3. What is the utilization of genetic resources?
    To conduct research and development on the genetic and/or biochemical composition of genetic resources, including through the application of biotechnology.
  4. What is traditional knowledge?
    The knowledge that is held by indigenous and local communities that could provide important lead information for the scientific discovery of interesting genetic or biochemical properties of genetic resources. Such traditional knowledge includes knowledge, innovations, and practices, of indigenous and local communities embodying traditional lifestyles, relevant for the conservation and sustainable use of biological diversity;
  5. What is due diligence?
    Due diligence implies meeting a reasonable standard of care, having ascertained that the genetic resources which you utilize have been accessed in accordance with the applicable access and benefit-sharing legislation or regulatory requirements of the provider countries of these genetic resources.
  6. What is prior informed consent (PIC)?
    Approval and involvement of indigenous and local communities obtained for access to genetic resources where they have the established right to grant access to such resources.
  7. What are mutually agreed terms (MAT)?
    The contractual arrangements concluded between a provider of genetic resources, or traditional knowledge associated with genetic resources, and a user, that set out specific conditions for the fair and equitable sharing of benefits arising from the utilization of genetic resources or of traditional knowledge associated with genetic resources.
  8. What is access?
    The acquisition of genetic resources or traditional knowledge associated with genetic resources in a Party to the Nagoya Protocol.
  9. What is biotechnology?
    Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.
  10. What is derivative?
    A naturally occurring biochemical compound resulting from the genetic expression or metabolism of biological or genetic resources, even if it does not contain functional units of heredity.